Cargando…

Vδ2(+) T Cells—Two Subsets for the Price of One

Detalles Bibliográficos
Autores principales:	Davey, Martin S., Willcox, Carrie R., Hunter, Stuart, Oo, Ye Htun, Willcox, Benjamin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167451/ https://www.ncbi.nlm.nih.gov/pubmed/30319605 http://dx.doi.org/10.3389/fimmu.2018.02106

Ejemplares similares

Development and Selection of the Human Vγ9Vδ2(+) T-Cell Repertoire
por: Willcox, Carrie R., et al.
Publicado: (2018)

The human Vδ2(+) T-cell compartment comprises distinct innate-like Vγ9(+) and adaptive Vγ9(-) subsets
por: Davey, Martin S., et al.
Publicado: (2018)

Recasting Human Vδ1 Lymphocytes in an Adaptive Role
por: Davey, Martin S., et al.
Publicado: (2018)

Human Vδ1(+) T Cells in the Immune Response to Plasmodium falciparum Infection
por: Hviid, Lars, et al.
Publicado: (2019)

Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations
por: Hunter, Stuart, et al.
Publicado: (2018)

Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance
por: Davey, Martin S., et al.
Publicado: (2017)

Characterization of a Putative Receptor Binding Surface on Skint-1, a Critical Determinant of Dendritic Epidermal T Cell Selection
por: Salim, Mahboob, et al.
Publicado: (2016)

Generation of Stable Isopentenyl Monophosphate Aryloxy Triester Phosphoramidates as Activators of Vγ9Vδ2 T Cells
por: Xu, Qin, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
por: Davey, Martin S., et al.
Publicado: (2018)

The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
por: Terry, Lauren V., et al.
Publicado: (2020)

γδ TCR Recognition of MR1: Adapting to Life on the Flip Side
por: Willcox, Benjamin E., et al.
Publicado: (2020)

Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function
por: Degirmencay, Abdullah, et al.
Publicado: (2023)

Transcriptional profiling of human Vδ1 T cells reveals a pathogen-driven adaptive differentiation program
por: McMurray, Jack L., et al.
Publicado: (2022)

Regulatory T Cell Metabolism in the Hepatic Microenvironment
por: Wawman, Rebecca Ellen, et al.
Publicado: (2018)

CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection
por: Dunne, Pádraic J., et al.
Publicado: (2018)

Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses
por: Kadri, Hachemi, et al.
Publicado: (2020)

Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
por: Karunakaran, Mohindar M., et al.
Publicado: (2020)

Evidence for an Adult-Like Type 1-Immunity Phenotype of Vδ1, Vδ2 and Vδ3 T Cells in Ghanaian Children With Repeated Exposure to Malaria
por: León-Lara, Ximena, et al.
Publicado: (2022)

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
por: Hoeres, Timm, et al.
Publicado: (2018)

Bordeaux 2018: Wine, Cheese, and γδ T Cells
por: Edelblum, Karen, et al.
Publicado: (2019)

Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives
por: Jeffery, Hannah C., et al.
Publicado: (2016)

Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
por: Bozward, Amber G., et al.
Publicado: (2021)

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells
por: Gu, Siyi, et al.
Publicado: (2015)

Role of Vγ9vδ2 T lymphocytes in infectious diseases
por: Gay, Laetitia, et al.
Publicado: (2022)

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
por: Ridgley, Laura A., et al.
Publicado: (2023)

Secondary structure and (1)H, (13)C and (15)N resonance assignments of Skint-1: a selecting ligand for a murine γδ T cell subset implicated in tumour suppression
por: Salim, M., et al.
Publicado: (2016)

Systematic pattern analyses of Vδ2(+) TCRs reveal that shared “public” Vδ2(+) γδ T cell clones are a consequence of rearrangement bias and a higher expansion status
por: Deng, Lihua, et al.
Publicado: (2022)

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection
por: Howard, Jennifer, et al.
Publicado: (2018)

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023)

Corrigendum: Systematic pattern analyses of Vδ2(+) TCRs reveal that shared “public” Vδ2(+) γδ T cell clones are a consequence of rearrangement bias and a higher expansion status
por: Deng, Lihua, et al.
Publicado: (2022)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Demonstration of Functional Heterogeneity of T lymphocytes and Identification of Their Two Major Subsets
por: Kisielow, Paweł
Publicado: (2014)

The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2
por: Shahzad, Shakeel, et al.
Publicado: (2022)

Bacterial outer-membrane vesicles promote Vγ9Vδ2 T cell oncolytic activity
por: Firth, Jack, et al.
Publicado: (2023)

Epstein–Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency
por: Carpier, Jean-Marie, et al.
Publicado: (2018)

Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
por: Wang, Zhan, et al.
Publicado: (2018)

Two Distinct Myeloid Subsets at the Term Human Fetal–Maternal Interface
por: Costa, Maria Laura, et al.
Publicado: (2017)

Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells
por: Harly, Christelle, et al.
Publicado: (2015)

Association of Decreased Percentage of Vδ2(+)Vγ9(+) γδ T Cells With Disease Severity in Multiple Sclerosis
por: Maimaitijiang, Guzailiayi, et al.
Publicado: (2018)

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
por: Holmen Olofsson, Gitte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5fmr0km40len7uj43ard0ab05